Stay updated on Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.

Latest updates to the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page
- Check6 days agoChange DetectedRevision: v3.3.3 was added to the Study Record Versions list, indicating a new update to the record. The footer now omits the HHS Vulnerability Disclosure link and Revision: v3.3.2.SummaryDifference0.2%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedThe Record History section shows minor updates: Revision: v3.3.2 was added and Revision: v3.3.1 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check35 days agoChange DetectedThe Record History shows a new Revision: v3.3.1 added and Revision: v3.2.0 removed, reflecting a minor update to the study record versions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check42 days agoChange DetectedA site-wide funding outage notice has been removed from the page, and the rest of the study record remains visible.SummaryDifference0.7%

- Check56 days agoChange DetectedA new version entry dated 2024-11-27 appears in the record history, showing updated study and recruitment status for NCT05560399. This reflects ongoing updates to the trial's official status on ClinicalTrials.gov.SummaryDifference0.1%

- Check85 days agoChange Detected- Added a government funding lapse notice and current operating status guidance for NIH Clinical Center, and a version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference12%

Stay in the know with updates to Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Iberdomide Combo with Elotuzumab in Myeloma Clinical Trial page.